These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 39024717)

  • 1. Tumor microenvironment-responsive cell-penetrating peptides: Design principle and precision delivery.
    Wang C; Wang B; Zhang Q; Zhang S
    Colloids Surf B Biointerfaces; 2024 Oct; 242():114100. PubMed ID: 39024717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
    Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
    Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
    Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
    J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
    Zorko M; Jones S; Langel Ü
    Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system].
    He F; Cao L; Zhang XJ; Xiang B; Cao DY; Qi XR
    Yao Xue Xue Bao; 2015 Feb; 50(2):141-7. PubMed ID: 25975019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways.
    Dowaidar M
    Mitochondrion; 2024 Sep; 78():101906. PubMed ID: 38797356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cell-penetrating peptides in potential anti-cancer therapy.
    Zhou M; Zou X; Cheng K; Zhong S; Su Y; Wu T; Tao Y; Cong L; Yan B; Jiang Y
    Clin Transl Med; 2022 May; 12(5):e822. PubMed ID: 35593206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting.
    Tang B; Zaro JL; Shen Y; Chen Q; Yu Y; Sun P; Wang Y; Shen WC; Tu J; Sun C
    J Control Release; 2018 Jun; 279():147-156. PubMed ID: 29653223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
    Zhang Q; Gao H; He Q
    Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
    Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation of cell-penetrating peptides: Functionality and potential clinical application.
    Reissmann S; Filatova MP
    J Pept Sci; 2021 May; 27(5):e3300. PubMed ID: 33615648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery.
    Gao H; Zhang Q; Yu Z; He Q
    Curr Pharm Biotechnol; 2014; 15(3):210-9. PubMed ID: 24938896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating peptides: strategies for anticancer treatment.
    Raucher D; Ryu JS
    Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
    Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
    Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.